RA Capital Management Lowers Stake in Achillion Pharma (ACHN) to 19.0%
Tweet Send to a Friend
In an amended13D filing on Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), hedge fund RA Capital Management disclosed a 19.0%, or 18,539,655 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE